500582 Sigma-AldrichInSolution™ Phorbol-12-myristate-13-acetate - CAS 16561-29-8 - Calbiochem
Recommended Products
Overview
Replacement Information |
---|
Key Spec Table
CAS # | Empirical Formula |
---|---|
16561-29-8 | C₃₆H₅₆O₈ |
Pricing & Availability
Catalogue Number | Availability | Packaging | Qty/Pack | Price | Quantity | |
---|---|---|---|---|---|---|
5.00582.0001 |
|
Botol kaca | 2 mg |
|
— |
Description | |
---|---|
Overview | Most commonly-used phorbol ester. Extremely potent mouse skin tumor promoter. Activates protein kinase C in vivo and in vitro, even at nM concentrations. Promotes the expression of iNOS in cultured hepatocytes. Activates Ca2+-ATPase and potentiates forskolin (Cat. No. 344270, Cat. No. 344282)-induced cAMP formation. Inhibits apoptosis induced by the Fas antigen, but induces apoptosis in HL-60 promyelocytic leukemia cells. Its binding is reversible. |
Catalogue Number | 500582 |
Brand Family | Calbiochem® |
Synonyms | 12-O-Tetradecanoyl-phorbol-13-acetate, PMA, TPA |
Product Information | |
---|---|
CAS number | 16561-29-8 |
Form | Liquid |
Formulation | A 10 mM (2 mg/324 µL) solution of Phorbol-12-myristate-13-acetate (Cat. No. 524400) in DMSO. |
Hill Formula | C₃₆H₅₆O₈ |
Chemical formula | C₃₆H₅₆O₈ |
Hygroscopic | Hygroscopic |
Reversible | Y |
Structure formula Image | |
Quality Level | MQ100 |
Applications |
---|
Biological Information | |
---|---|
Primary Target | PKC |
Secondary target | Ca2+-ATPase |
Purity | ≥98% by HPLC |
Physicochemical Information | |
---|---|
Cell permeable | Y |
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Product Usage Statements |
---|
Packaging Information | |
---|---|
Packaged under inert gas | Packaged under inert gas |
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Catalogue Number | GTIN |
5.00582.0001 | 04055977244977 |
Documentation
InSolution™ Phorbol-12-myristate-13-acetate - CAS 16561-29-8 - Calbiochem MSDS
Title |
---|
References
Reference overview |
---|
Powell, D.J., et al. 2003. Mol. Cell Biol. 23, 7794. Tepper, C.G., et al. 1995. Proc. Natl. Acad. Sci. USA 92, 8443. Oishi, K., and Yamaguchi, M. 1994. J. Cell. Biochem. 55, 168. Macfarlane, D.E., and O'Donnell, P.S. 1993. Leukemia 7, 1846. Ghandi, V.C. and Jones, D.J., 1992. Neuropharmacol. 31, 1101. Hortelano, S., et al. 1992. J. Biol. Chem. 267, 24937. Kontny, E., et al. 1992. Eur. J. Pharmacol. 227, 333. Zanaboni, P.B., et al. 1992. J. Appl. Physiol. 73, 2011. Saltis, J., et al. 1991. J. Biol. Chem. 266, 261. Beguinot, L., et al. 1985. Proc. Natl. Acad. Sci. USA 82, 2774. Perchellet, J. 1985. Carcinogenesis 6, 567. Nishizuka, Y. 1984. Science 255, 1365. Mastro, A. 1982. Lymphokines 6, 263. |
Data Sheet | ||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.
|